Pre-transplant positron emission tomography (PET) using fluorine-18-fluoro-deoxyglucose (FDG) predicts outcome in patients treated with high-dose chemotherapy and autologous stem cell transplantation for non-Hodgkin's lymphoma.

PubWeight™: 0.91‹?›

🔗 View Article (PMID 12132049)

Published in Bone Marrow Transplant on July 01, 2002

Authors

U Cremerius1, U Fabry, J E Wildberger, M Zimny, P Reinartz, B Nowak, W Schaefer, U Buell, R Osieka

Author Affiliations

1: Department of Nuclear Medicine, Aachen University of Technology, Pauwelsstr 30, 52057 Aachen, Germany.

Articles citing this

Predictive role of positron emission tomography (PET) in the outcome of lymphoma patients. Br J Cancer (2004) 1.10

Current role of FDG PET/CT in lymphoma. Eur J Nucl Med Mol Imaging (2014) 1.06

FDG PET and risk-adapted therapy in Hodgkin's and non-Hodgkin's lymphoma. Curr Opin Oncol (2008) 1.03

Stem cell transplantation in brain tumors: a new field for molecular imaging? Mol Med (2010) 0.99

Positron emission tomography with [(18)F]FDG for therapy response monitoring in lymphoma patients. Eur J Nucl Med Mol Imaging (2003) 0.94

Fluorine-18-fluorodeoxyglucose positron emission tomography in response assessment before high-dose chemotherapy for lymphoma: a systematic review and meta-analysis. Oncologist (2010) 0.91

Non-Hodgkin lymphoma: retrospective study on the cost-effectiveness of early treatment response assessment by FDG-PET. Eur J Nucl Med Mol Imaging (2008) 0.90

PET/CT in oncology: for which tumours is it the reference standard? Cancer Imaging (2007) 0.90

Unifying the predictive value of pretransplant FDG PET in patients with lymphoma: a review and meta-analysis of published trials. Eur J Nucl Med Mol Imaging (2010) 0.86

Use of FDG-PET to monitor response to chemotherapy and radiotherapy in patients with lymphomas. Eur J Nucl Med Mol Imaging (2006) 0.83

Early post transplant (F-18) 2-fluoro-2-deoxyglucose positron emission tomography does not predict outcome for patients undergoing auto-SCT in non-Hodgkin and Hodgkin lymphoma. Bone Marrow Transplant (2010) 0.82

Molecular imaging of stem cell therapy in brain tumors: a step towards personalized medicine. Arch Med Sci (2012) 0.80

PET in lymphoma. Cancer Imaging (2006) 0.77

Diffuse Large B-Cell Lymphoma in the Era of Precision Oncology: How Imaging Is Helpful. Korean J Radiol (2017) 0.75

Articles by these authors

A phase I clinical, plasma, and cellular pharmacology study of gemcitabine. J Clin Oncol (1991) 3.96

Detection and characterization of multiple forms of simian virus 40 large T antigen. J Virol (1981) 2.54

Characterization of monoclonal antibodies and polyclonal immune sera directed against human cytomegalovirus virion proteins. Virology (1984) 2.48

Multidetector CT of the spine in multiple myeloma: comparison with MR imaging and radiography. AJR Am J Roentgenol (2002) 1.87

Physical mapping of human cytomegalovirus genes: identification of DNA sequences coding for a virion phosphoprotein of 71 kDa and a viral 65-kDa polypeptide. Virology (1984) 1.81

2-[Fluorine-18]-fluoro-2-deoxy-d-glucose positron emission tomography in the diagnosis of recurrent ovarian cancer. Gynecol Oncol (2001) 1.79

64-slice computed tomography assessment of coronary artery stents: a phantom study. Acta Radiol (2006) 1.57

Does thyroid stunning exist? A model with benign thyroid disease. Eur J Nucl Med (2000) 1.50

How can we identify the best implantation site for an ECG event recorder? Pacing Clin Electrophysiol (2000) 1.50

FDG PET for detection and therapy control of metastatic germ cell tumor. J Nucl Med (1998) 1.43

Auxiliary rat liver transplantation with portal vein arterialization in acute hepatic failure. Transplantation (2000) 1.39

Chemotherapy of human colon cancer xenografts in athymic nude mice. Cancer (1977) 1.39

Calcium scoring of aortic valve calcification in aortic valve stenosis with a multislice computed tomography scanner: non-enhanced versus contrast-enhanced studies. Acta Radiol (2005) 1.38

Immunization of HIV-infected children with varicella vaccine. J Pediatr (2001) 1.35

Genome structure and virion polypeptides of the primate herpesviruses Herpesvirus aotus types 1 and 3: comparison with human cytomegalovirus. J Virol (1983) 1.32

Improved outcome in adult B-cell acute lymphoblastic leukemia. Blood (1996) 1.26

Clinical pharmacology of sodium butyrate in patients with acute leukemia. Eur J Cancer Clin Oncol (1987) 1.25

The contribution of magnetic resonance imaging of the pelvic floor to the understanding of urinary incontinence. Br J Urol (1993) 1.25

Visual symmetry recognition by pigeons. Psychol Res (1982) 1.23

DNA methylation changes in multiple myeloma. Leukemia (2004) 1.23

[Guidelines for heart pacemaker therapy]. Z Kardiol (2005) 1.22

Aneurysmal bone cyst: value of MR imaging and conventional radiography. Eur Radiol (2002) 1.22

Diagnostic and therapeutic management of lumbar and thoracic spondylodiscitis--an evaluation of 59 cases. Arch Orthop Trauma Surg (2000) 1.22

Radionuclide imaging of the painful hip arthroplasty: positron-emission tomography versus triple-phase bone scanning. J Bone Joint Surg Br (2005) 1.19

In vivo resistance towards anthracyclines, etoposide, and cis-diamminedichloroplatinum(II). Cancer Res (1982) 1.18

Radiation doses of collimated vs non-collimated cephalometric exposures. Dentomaxillofac Radiol (2003) 1.17

Measurement of DNA damage in unlabeled mammalian cells analyzed by alkaline elution and a fluorometric DNA assay. Anal Biochem (1980) 1.16

Detection of apoptosis in KG-1a leukemic cells treated with investigational drugs. Arzneimittelforschung (1996) 1.14

The role of magnetic resonance imaging in assessing residual disease and pathologic complete response in breast cancer patients receiving neoadjuvant chemotherapy: a systematic review. Insights Imaging (2013) 1.14

Diagnosis and staging of head and neck cancer: a comparison of modern imaging modalities (positron emission tomography, computed tomography, color-coded duplex sonography) with panendoscopic and histopathologic findings. Arch Otolaryngol Head Neck Surg (2000) 1.11

Success rate of radioiodine therapy in Graves' disease: the influence of thyrostatic medication. J Clin Endocrinol Metab (1999) 1.08

Diagnostic evaluation of malignant head and neck cancer by F-18-FDG PET compared to CT/MRI. Nuklearmedizin (1999) 1.08

Asparaginylglucose: Novel type of carbohydrate linkage. Proc Natl Acad Sci U S A (1983) 1.08

Saturation of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate accumulation in leukemia cells during high-dose 1-beta-D-arabinofuranosylcytosine therapy. Cancer Res (1987) 1.08

Guide to the identification of fish protozoan and metazoan parasites in stained tissue sections. Dis Aquat Organ (2006) 1.07

Suppression of allergic reaction by lambda-carrageenan: toll-like receptor 4/MyD88-dependent and -independent modulation of immunity. Clin Exp Allergy (2003) 1.07

Diagnostic values of positron emission tomography versus triple-phase bone scan in hip arthroplasty loosening. Arch Orthop Trauma Surg (2005) 1.06

Acute myeloid leukaemia with t(8;21) associated with "occult" mastocytosis. Report of an unusual case and review of the literature. J Clin Pathol (2004) 1.06

The large striatocapsular infarct. A clinical and pathophysiological entity. Arch Neurol (1990) 1.06

Detection of some murine leukemia virus antigens in virus particles derived from 3T3 cells transformed only by murine sarcoma virus. Virology (1972) 1.06

A defect in bone marrow derived dendritic cell maturation in the nonobesediabetic mouse. Clin Exp Immunol (2001) 1.05

Radiation dose reduction to breast and thyroid during MDCT: effectiveness of an in-plane bismuth shield. Acta Radiol (2006) 1.05

Gemcitabine: a phase II study in patients with advanced renal cancer. Cancer Chemother Pharmacol (1996) 1.03

Individually weight-adapted examination protocol in retrospectively ECG-gated MSCT of the heart. Eur Radiol (2003) 1.02

Neuropsychological impairment correlates with hypoperfusion and hypometabolism but not with severity of white matter lesions on MRI in patients with cerebral microangiopathy. Stroke (1999) 1.01

Percutaneous treatment of thrombosed primary arteriovenous hemodialysis access fistulae. Kidney Int (2000) 1.01

The role of dual energy CT in differentiating between brain haemorrhage and contrast medium after mechanical revascularisation in acute ischaemic stroke. Eur Radiol (2013) 1.00

Epigenetic inactivation of secreted Frizzled-related proteins in acute myeloid leukaemia. Br J Haematol (2008) 1.00

Clinical and hemodynamic aspects of low-flow infarcts. Stroke (1991) 1.00

Phase I study of recombinant human tumor necrosis factor alpha in advanced malignant disease. Cancer Immunol Immunother (1989) 0.99

Recurrent bacteremia due to Brevibacterium casei in an immunocompromised patient. Eur J Clin Microbiol Infect Dis (1995) 0.99

The case of aphasia or neglect after striatocapsular infarction. Brain (1993) 0.99

Fluorine-18 fluorodeoxyglucose positron emission tomography in the differential diagnosis of pancreatic carcinoma: a report of 106 cases. Eur J Nucl Med (1997) 0.99

Correlation of positive symptoms exclusively to hyperperfusion or hypoperfusion of cerebral cortex in never-treated schizophrenics. Lancet (1997) 0.98

Taurine chloramine down-regulates the generation of murine neutrophil inflammatory mediators. Immunopharmacology (1998) 0.98

Regional cerebral blood flow and negative/positive symptoms in 24 drug-naive schizophrenics. J Nucl Med (1997) 0.98

Myocyte degeneration and cell death in hibernating human myocardium. J Am Coll Cardiol (1996) 0.97

Diagnostic value of stored electrograms in single-lead VDD systems. Pacing Clin Electrophysiol (2000) 0.96

Pneumatosis intestinalis following cytotoxic or immunosuppressive treatment. Digestion (2001) 0.96

[Visualization of coronary arteries in CT as assessed by a new 16 slice technology and reduced gantry rotation time: first experiences]. Rofo (2002) 0.96

Patent foramen ovale closure in patients with transient ischemia attack/stroke. J Interv Cardiol (2001) 0.96

Epigenetic alterations complement mutation of JAK2 tyrosine kinase in patients with BCR/ABL-negative myeloproliferative disorders. Leukemia (2007) 0.95

Contrast enhanced mammography: techniques, current results, and potential indications. Clin Radiol (2013) 0.95

Cross-sectional imaging patterns of desmoplastic fibroma. Eur Radiol (2001) 0.95

Fluorodeoxyglucose positron emission tomography and the prognosis of pancreatic carcinoma. Scand J Gastroenterol (2000) 0.95

Influence of diabetes mellitus on regional cerebral glucose metabolism and regional cerebral blood flow. Nucl Med Commun (2000) 0.95

Prolonged myocardial hibernation exacerbates cardiomyocyte degeneration and impairs recovery of function after revascularization. J Am Coll Cardiol (1998) 0.95

Estimation of radiation exposure in low-dose multislice computed tomography of the heart and comparison with a calculation program. Eur Radiol (2006) 0.94

[Scintigraphically "hot" thyroid nodules mainly go hand in hand with a normal TSH]. Nuklearmedizin (2011) 0.94

Peripheral neuropathy and ophthalmologic toxicity after treatment with cis-dichlorodiaminoplatinum II. J Cancer Res Clin Oncol (1980) 0.94

Modulation of the cellular metabolism of cytarabine and fludarabine by granulocyte-colony-stimulating factor during therapy of acute myelogenous leukemia. Clin Cancer Res (1995) 0.94

A comparison of the effective dose from scanography with periapical radiography. Dentomaxillofac Radiol (2002) 0.94

Enhancement of etoposide-induced cytotoxicity by cyclosporin A. Cancer Chemother Pharmacol (1986) 0.93

Does positron emission tomography using 18-fluoro-2-deoxyglucose improve clinical staging of testicular cancer?--Results of a study in 50 patients. Urology (1999) 0.93

Prostate-specific antigen as a marker of bone metastasis in patients with prostate cancer. Urol Int (1996) 0.92

Radiation doses of indirect and direct digital cephalometric radiography. Br Dent J (2004) 0.92

MDCT angiography of the pulmonary arteries: intravascular contrast enhancement does not depend on iodine concentration when injecting equal amounts of iodine at standardized iodine delivery rates. Eur Radiol (2008) 0.91

Regulation of murine dendritic cell functions in vitro by taurine chloramine, a major product of the neutrophil myeloperoxidase-halide system. Immunology (1999) 0.91

Cardiac stress-rest single-photon emission computed tomography with technetium 99m-labeled tetrofosmin: influence of washout kinetics on regional myocardial uptake values of the rest study with a 1-day protocol. J Nucl Cardiol (1997) 0.90

Localisation of motor areas in brain tumour patients: a comparison of preoperative [18F]FDG-PET and intraoperative cortical electrostimulation. Eur J Nucl Med (2001) 0.90

Antimicrobial and cytotoxic activity of hypochlorous acid: interactions with taurine and nitrite. Inflamm Res (2000) 0.90

Metabolic and electrophysiological validation of functional MRI. J Neurol Neurosurg Psychiatry (2001) 0.89

High-performance liquid chromatography method for the determination and quantitation of arabinosylguanine triphosphate and fludarabine triphosphate in human cells. J Chromatogr B Biomed Sci Appl (2000) 0.89

Noninvasive coronary angiography using 64-detector-row computed tomography in patients with a low to moderate pretest probability of significant coronary artery disease. Acta Radiol (2007) 0.89

Expression of apoptosis-related oncoproteins and modulation of apoptosis by caffeine in human leukemic cells. J Cancer Res Clin Oncol (1995) 0.89